Wednesday, 2 July 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 02 July 2025
News

July notches seven PBS listings

Posted 2 July 2025 AM

There have been seven additions to the PBS this month, including two new medicines, a biosimilar, and four expansions for big brands.

Among the newbies is Servier’s first-in-class IDH1 inhibitor Tibsovo, which has been subsidised for the treatment of adults with locally advanced or metastatic cholangiocarcinoma who have previously progressed on chemotherapy and have a confirmed IDH1 mutation. The company won a recommendation for the drug at the November 2024 meeting via the early re-entry pathway.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (10)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (1)

Devices (1)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.